Skip to content
Search

Latest Stories

Submit Guest Post

Some ultra-processed foods beneficial for health: Study

Despite being classified as ultra-processed foods, bread and cereals were found to reduce the risk of cancer, heart disease, and diabetes

Some ultra-processed foods beneficial for health: Study

Certain ultra-processed foods increase the risk of developing cancer, heart disease, and diabetes, but new research suggests that some of these foods are beneficial for health.

Regular consumption of meat products such as sausages and sugary drinks is associated with a higher likelihood of developing such diseases.


However, despite being classified as ultra-processed foods, bread, and cereals that contain fibre were found to reduce the risk of these diseases, The Guardian reported.

The study also found that sauces, spreads, and condiments have negative health effects, but not to the same extent as animal products and soft drinks. The findings were published in The Lancet.

The latest research challenges the notion that all ultra-processed foods (UPF) are harmful to health.

Sweets, desserts, ready meals, savoury snacks, and plant-based alternatives to meat products were found to be "not associated with the risk of multimorbidity," according to the authors.

This nuanced approach contradicts the broad categorisation of all UPF as detrimental to health and highlights specific products that may not pose the same risks.

The study, conducted across seven European countries, involved an analysis of the dietary habits and health conditions of 266,666 individuals.

The findings revealed that a higher intake of ultra-processed foods correlated with an increased risk of multimorbidity, including cancer and cardiometabolic diseases.

The researchers suggested that individuals looking to mitigate their risk could consider replacing some UPF in their diet with less processed alternatives or adopt a Mediterranean diet for the prevention of cancer and cardiometabolic multimorbidity.

Multimorbidity refers to the simultaneous presence of at least two life-shortening diseases, such as cancer and heart disease.

The growing apprehension surrounding UPF has been intensified by the revelation that 50%-60% of total energy intake in certain high-income countries is derived from UPF rather than freshly prepared meals.

Heinz Freisling, a co-author of the study and an expert at the International Agency for Research on Cancer (IARC), emphasised that the study doesn't advocate complete avoidance of UPF but suggests limiting their consumption and prioritising fresh or minimally processed foods.

Reynalda Cordova, leading the study at both IARC and the University of Vienna, emphasised the importance of providing consumers with easy access to fresh and less-processed foods.

Dr Ian Johnson, a nutrition researcher, and emeritus fellow at the Quadram Institute, noted that the study provided valuable insights into which types of UPFs were harmful and which were not.

“These observations do suggest a role for some UPF in the onset of multiple chronic disease. But they also show that the common assumption that all UPF foods are linked to adverse health events is probably wrong.”

Dr Duane Mellor, a senior lecturer at Aston University’s medical school, agreed, and said that the concept of UPF is too broad.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less